“…Thereafter, several in vivo skin cancer studies have been performed with DMBA/TPA [46,[199][200][201]235,236], DMBA alone, [237-239], TPA alone [240][241][242], ultraviolet B radiation (UVB) exposure [202][203][204]243], benzo[a]pyrene (BP) [237], and xenograft models [198]. In the DMBA/TPA models, resveratrol treatment reduced the incidence [46,[199][200][201]235], multiplicity [46,199,201,235], and tumor volume [201,235,236], and delayed the onset of tumorigenesis [201].…”